Qiagen invests in next-gen sequencing tech; Biopharma consulting firm sold for £50M; New tally puts swine flu deaths at about 284,500;

 @FierceBiotech: Promising RA antibody data may help encourage new Ablynx partnership. Story | Follow @FierceBiotech

 @JohnCFierce: Does this controversy have legs? Maybe so. FDA review cites Amylin for withholding data on Bydureon app. Story | Follow @JohnCFierce

 @RyanMFierce: My interviews with eclinical CEOs at DIA 2012 about mobile, remote site monitoring, Microsoft partnerships: More | Follow @RyanMFierce

> Qiagen says it plans to invest heavily in next-gen sequencing technology with an eye to making it a routine part of the clinical research and molecular diagnostics fields. Release

> McCann Health reportedly has snagged a £50 million deal to buy Double Helix, a prominent U.K. consultancy that provides strategic research to biotech and pharma companies. Story

> MAP Pharmaceuticals says that it will resubmit its migraine therapy to the FDA later this year. Story

Pharma News

@FiercePharma: Check out our special report: Pharma's Top 10 Marketing Settlements. Approx. $11 bn over 10 years. Special Report | Follow @FiercePharma

> Whistleblowers: Merck hid declining efficacy of MMR shot. Story

> FDA chief says safety trumps job creation. Article

Medical Device News

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: Another day, another deal closes. Covidien is now the proud new owner of Oridion Systems. The cost: $310M. Release | Follow @MarkHFierce

 @DamianFierce: Getting ahead of the pending device tax, Stryker has started its rolling layoffs, looking to cut 107 jobs. More | Follow @DamianFierce

> FDA OKs first glaucoma stent for cataract surgery. News

> User fee bill heads to White House. Story

> Following the U.K., FDA wants to take a hard look at hip implants. Article

Biotech Research News

> Scientists wield human stem cells to engineer blood-brain barrier structures. Story

> Cleveland BioLabs drug, chemo kill neuroblastomas in mice. Item

> U.K. researchers enhance tracking for stem cell injections. Article

> At long last, 2nd controversial look at bird flu virus finally published. More

Pharma Manufacturing News

> Sanofi plant problems result in vaccine shortage. News

> Novartis plant in Russia two years out. More

> Fake Viagra apparently sourced in China. Article

> Import alert lifted for AkzoNobel Mexico plant. Story

And Finally… Investigators say that swine flu evidently killed about 284,500 people, 15 times as many deaths as were confirmed by lab tests. And half the deaths occurred in southeast Asia and Africa. Report

 

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.